MetaCap

Precision BioSciences (DTIL) vs SL Science (SLBT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Precision BioSciences (DTIL) has outperformed SL Science (SLBT) over the past year, gaining 48.0% versus a loss of 94.8%. SL Science is the larger company by market cap ($308.4 million vs $282.5 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

DTIL+48.00%SLBT-94.76%
+122%+9%-105%
Nov 21, 20251 yearNov 20, 2026
DTIL+57.45%SLBT-94.51%
+137%+16%-106%
Feb 3, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DTIL versus SLBT key metrics
MetricDTILSLBT
Share price$7.40$0.55
Market cap$282.46M$308.42M
1-day change+7.09%-3.36%
YTD return+77.88%-94.78%
1-year return+48.00%-94.76%
5-year return-97.23%—
P/E ratio (TTM)29.60—
EPS (TTM)$0.25$0.00
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$34.26M—
Revenue growth (YoY)-50.12%—
Net income (latest FY)$-45.72M—
Operating margin-152.19%—
Net margin-133.45%—
52-week high$11.29$14.50
52-week low$3.53$0.51
Distance from 52-week high-34.46%-96.21%
Analyst consensusstrong_buy—
Avg. price target upside+297.30%—
Average volume319.79K67.66K
Shares outstanding38.17M560.76M
Employees6914
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • DTIL has outperformed SLBT by 142.8 percentage points over the past year.

About Precision BioSciences

DTIL stock →

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 69 employees

About SL Science

SLBT stock →

SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 14 employees

DTIL vs SLBT FAQ

Which is bigger, Precision BioSciences or SL Science?

SL Science (SLBT) is larger, with a market capitalization of $308.42M compared with $282.46M for Precision BioSciences (DTIL).

Which stock has performed better over the past year, DTIL or SLBT?

DTIL returned +48.00% over the past 12 months, compared with -94.76% for SLBT (price return, excluding dividends). Past performance does not predict future results.

Are Precision BioSciences and SL Science in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons